1. Scrip
  2. >>Business

Coronavirus Update: US Considers Half Dose Of Moderna Vaccine To Maximize Coverage

UK And US Look To Increase Vaccination Rate

 
• By Scrip Team

Operation Warp Speed leader wants to look at half dose of Moderna vaccine - but pledges that final decision will belong to the US FDA.  

UK covid-19 vaccinations begin
The UK has administered just over 1 million doses of COVID-19 vaccines, and the US 4.3 million - far behind where they had planned to be.

US vaccine leaders have dismissed the UK’s strategy of delaying a second dose of COVID-19 vaccines – but are considering using a half dose of Moderna’s vaccine to help maximize its national vaccination roll-out.

Both countries are facing a huge renewed surge in cases, with fears that the Christmas and New Year holidays will have fueled the spread of infection, along with the threat of the new, much

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Business

More from Scrip

Finance Watch: Deerfield Closes $600m-Plus VC Fund; Gates Speeds Up Health Investments

 
• By Mandy Jackson

Private Company Edition: Deerfield’s third innovations fund will back therapeutics and other opportunities, the Gates Foundation – a sometimes funder of biotech firms – will spend $200bn over the next 20 years, and NewLimit raised a $130m series B round, among other financings.

Pipeline Watch: Six Approvals And Thirteen Phase III Readouts

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

Pharma Left Hanging After US/UK Trade Pact

 
• By Kevin Grogan

An ‘historic economic prosperity deal’ does not include the sector.